Efficient Quantitative Analysis of THC and its Metabolites in Whole Blood Using Agilent Captiva EMR—Lipid and LC-MS/MS

Importance of the Topic

Efficient and reliable quantification of Δ9-tetrahydrocannabinol (THC) and its primary metabolites in whole blood is critical for forensic investigations and traffic safety enforcement. Phospholipids in blood often cause ion suppression in LC-MS/MS, leading to inaccurate results and instrument contamination. A streamlined sample preparation method that removes these interferences without sacrificing analyte recovery improves data quality, reduces downtime, and supports rapid case turnaround.

Objectives and Overview

This study aimed to develop a robust workflow for extraction, cleanup, and LC-MS/MS analysis of THC, 11-hydroxy-THC (THC-OH), and 11-nor-9-carboxy-THC (THC-COOH) from whole blood. The key goals were to eliminate phospholipid interferences, achieve low limits of quantitation, and maintain high precision and accuracy over multiple days.

Methodology and Instrumentation

Sample Preparation

• In-well protein precipitation: 500 μL cold MeOH:ACN (15:85) added to 100 μL whole blood in a Captiva EMR–Lipid 1 mL cartridge.
• Active mixing for 5–7 minutes followed by low-pressure vacuum (3.5–4 psi) to remove precipitated proteins.
• Addition of 200 μL cold H2O:ACN (1:4) and higher-pressure vacuum to elute analytes while trapping phospholipids.
• Evaporation and reconstitution in 100 μL MeOH (0.1% formic acid); online dilution in the LC autosampler with 10 μL water.

Instrumentation

• Agilent 1290 Infinity LC System with 6490 Triple Quadrupole MS.
• Column: ZORBAX RRHD Bonus RP, 2.1×50 mm, 1.8 μm, 50 °C.
• Mobile phase: 5 mM ammonium formate with 0.1% formic acid (water and methanol) gradient (65–95% B over 5 min).
• ESI positive mode, multiple reaction monitoring for analytes and eleven phospholipid markers.

Main Results and Discussion

Phospholipid Removal

• Captiva EMR–Lipid removed over 97% of monitored phospholipids, minimizing ion suppression.
• Analyte recovery exceeded 92% across THC and metabolites due to selective sorbent chemistry that traps unbranched lipid chains while excluding bulky analytes.

Chromatographic and Quantitative Performance

• LC-MS/MS chromatograms at 1 ng/mL spiking showed sharp, well-resolved peaks with signal-to-noise ratios suitable for forensic thresholds (5 ng/mL).
• Calibration was linear from 0.5 to 100 ng/mL (R2 > 0.99) for all compounds.
• Limits of quantitation were ≤1.0 ng/mL with inter- and intra-day precision (RSD) below 11.5% over three days.

Benefits and Practical Applications

The described workflow reduces sample handling steps, minimizes matrix effects, and protects the LC-MS/MS system from lipid contamination. In-well cleanup eliminates centrifugation transfers and supports high throughput. Laboratories benefit from improved data integrity, lower maintenance, and rapid turnaround for casework and DUID (driving under the influence of drugs) analyses.

Future Trends and Applications

Advancements may include automation of EMR-Lipid cleanup in 96-well formats, integration with high-resolution mass spectrometry for broader screening, and expansion to other challenging matrices (e.g., oral fluid, tissue homogenates). Emerging sorbent technologies targeting other classes of matrix interferences will further streamline bioanalytical workflows.

Conclusion

The Agilent Captiva EMR–Lipid method combined with LC-MS/MS delivers a rapid, robust approach for quantifying THC and its metabolites in whole blood. Phospholipid removal exceeds 97%, recoveries surpass 92%, and sensitivity meets forensic requirements. The protocol enhances laboratory efficiency and analytical confidence for forensic toxicology.

References

1. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Anal Chem. 2003;75(13):3019–3030.
2. Jamey C, et al. J Anal Toxicol. 2008;32:349–354.
3. Stevens J, Zhao L. Agilent Technologies Application Note 5991-8636, 2017.
4. Elian A, Hackett J. J Anal Toxicol. 2009;33:461–468.
5. Sorensen L, Hasselstrom J. J Anal Toxicol. 2017;41:382–391.